ProPublica reports VA is run by informal 'Mar-a-Lago Crowd'

Three members of President Donald Trump’s private beach club, Mar-a-Lago, are running the show at the U.S. Department of Veteran Affairs (VA) despite not being government officials or veterans, according to a bombshell report by ProPublica. 

The news comes months after a story broke that Trump’s associates, who don’t officially work for the administration, were holding up a $16 billion deal to replace the electronic health records system at the VA.

The revelations come as the Trump administration has continually urged more private healthcare to be ushered into the VA.

The men identified as the “shadow leaders” of the VA include Palm Beach doctor Bruce Moskowitz, MD; Marc Sherman, a lawyer; and Marvel Entertainment Chairman Ike Perlmutter, who acts as a secret, pseudo-leader of the VA, according to ProPublica.

The involvement of the three Mar-a-Lago members in the VA has led to healthcare policy shifts, program developments and leadership changes, according to the report. However, the three are not officials at the VA or within the Trump administration, nor have they served in the U.S. military or government in any capacity.

Still, VA officials have been working with the men since President Trump’s inauguration, with department leadership flying to meet with the trio on the taxpayer’s dime. The advice offered by the “cronies” is taken as orders by VA staff, rather than advice or recommendations from outside sources, ProPublica reported.

Read the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.